{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T02:34:07Z","timestamp":1740105247479,"version":"3.37.3"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["heartandlung.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart & Lung"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.hrtlng.2024.04.001","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T22:25:05Z","timestamp":1712701505000},"page":"94-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The findings of a service evaluation on the practice of assessment and treatment of iron deficiency in people admitted to a UK hospital with decompensated Heart Failure"],"prefix":"10.1016","volume":"66","author":[{"given":"Rebecca","family":"Bone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Walthall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"36","key":"10.1016\/j.hrtlng.2024.04.001_bib0001","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrtlng.2024.04.001_bib0002","unstructured":"British Heart Foundation. Focus on heart failure. 2016. https:\/\/www.bhf.org.uk\/-\/media\/files\/what-we-do\/influencing-change\/appg-on-heart-disease-focus-on-heart-failure-report.pdf?rev=4435f31c724049408229e3d8d3654f5c. Accessed July 20, 2023."},{"journal-title":"Managing Heart Failure @home: An Opportunity for Excellence","year":"2023","author":"Linker","key":"10.1016\/j.hrtlng.2024.04.001_bib0003"},{"key":"10.1016\/j.hrtlng.2024.04.001_bib0004","series-title":"British Heart Foundation","article-title":"Heart failure hospital admissions rise by a third in five years","author":"Blake","year":"2023"},{"issue":"7","key":"10.1016\/j.hrtlng.2024.04.001_bib0005","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jacc.2017.12.027","article-title":"The burden of iron deficiency in heart failure","volume":"71","author":"Rocha","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.hrtlng.2024.04.001_bib0006","article-title":"Definition of iron deficiency based on the gold standard of bone marrow iron staining in heart failure patients","volume":"11","author":"N","year":"2018","journal-title":"Circ Heart Fail"},{"issue":"4","key":"10.1016\/j.hrtlng.2024.04.001_bib0007","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jacc.2021.11.039","article-title":"Criteria for Iron deficiency in patients with heart failure","volume":"79","author":"Masini","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.hrtlng.2024.04.001_bib0008","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1093\/eurheartj\/ehad154","article-title":"Redefining both iron deficiency and anaemia in cardiovascular disease","volume":"44","author":"Cleland","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrtlng.2024.04.001_bib0009","first-page":"ehae086","article-title":"Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial","author":"Cleland","year":"2024","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.hrtlng.2024.04.001_bib0010","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000358377","article-title":"Iron deficiency status irrespective of anemia: a predictor of unfavorable outcome in chronic heart failure patients","volume":"128","author":"Rangel","year":"2014","journal-title":"Cardiology"},{"year":"2015","series-title":"Hoffbrand's Essential Haematology","author":"Hoffbrand","key":"10.1016\/j.hrtlng.2024.04.001_bib0011"},{"issue":"25","key":"10.1016\/j.hrtlng.2024.04.001_bib0012","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.hrtlng.2024.04.001_bib0013","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"issue":"10266","key":"10.1016\/j.hrtlng.2024.04.001_bib0014","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski","year":"2020","journal-title":"Lancet"},{"issue":"10369","key":"10.1016\/j.hrtlng.2024.04.001_bib0015","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/S0140-6736(22)02083-9","article-title":"Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial","volume":"400","author":"Kalra","year":"2022","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.hrtlng.2024.04.001_bib0016","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1001\/jama.2017.5427","article-title":"Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: The IRONOUT HF randomized clinical trial","volume":"317","author":"Lewis","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.hrtlng.2024.04.001_bib0017","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/13696998.2022.2155375","article-title":"Clinical and economic impact of ferric carboxymaltose treatment for iron deficiency in patients stabilized following acute heart failure: a multinational study","volume":"26","author":"McEwan","year":"2023","journal-title":"J Med Econ"},{"key":"10.1016\/j.hrtlng.2024.04.001_bib0018","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.2810","article-title":"Intravenous iron in patients with heart failure and iron deficiency: an updated meta-analysis","author":"Graham","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"37","key":"10.1016\/j.hrtlng.2024.04.001_bib0019","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"article-title":"Chronic heart failure in adults. Diagnosis and management","year":"2018","series-title":"NG106 Full Guideline","key":"10.1016\/j.hrtlng.2024.04.001_bib0020"},{"issue":"18","key":"10.1016\/j.hrtlng.2024.04.001_bib0021","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.hrtlng.2024.04.001_bib0022","unstructured":"Scottish Intercollegiate Guidelines Network. SIGN 147 Management of chronic heart failure. 2016. https:\/\/www.sign.ac.uk\/media\/1083\/sign147.pdf. Accessed April 27, 2023."},{"issue":"4","key":"10.1016\/j.hrtlng.2024.04.001_bib0023","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.5114\/aoms\/136068","article-title":"Iron deficiency correction in heart failure patients with preserved ejection fraction: a case series study","volume":"17","author":"Cosentino","year":"2021","journal-title":"Arch Med Sci"},{"issue":"23","key":"10.1016\/j.hrtlng.2024.04.001_bib0024","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.3390\/nu14235057","article-title":"Effect of ferric carboxymaltose supplementation in patients with heart failure with preserved ejection fraction: role of attenuated oxidative stress and improved endothelial function","volume":"14","author":"Mollace","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.hrtlng.2024.04.001_bib0025","article-title":"Effect of IV iron in patients with heart failure with preserved ejection fraction (FAIR-HFpEF)","author":"Doehner","year":"2023","journal-title":"ClinicalTrials.gov"},{"issue":"3","key":"10.1016\/j.hrtlng.2024.04.001_bib0026","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1016\/j.ijcard.2013.01.249","article-title":"The missed opportunities to diagnose and treat iron deficiency in patients hospitalized with heart failure","volume":"168","author":"Silverberg","year":"2013","journal-title":"Int J Cardiol"},{"issue":"10","key":"10.1016\/j.hrtlng.2024.04.001_bib0027","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s00277-019-03777-w","article-title":"Iron deficiency in heart failure, an underdiagnosed and undertreated condition during hospitalization","volume":"98","author":"Mistry","year":"2019","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1016\/j.hrtlng.2024.04.001_bib0028","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/ehf2.13245","article-title":"Diagnosis and treatment of iron deficiency in heart failure: OFICSel study by the French Heart Failure Working Group","volume":"8","author":"Pezel","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.hrtlng.2024.04.001_bib0029","first-page":"14","article-title":"Study of patients with iron deficiency and HF in Ireland: prevalence and treatment budget impact","volume":"28","author":"Wong","year":"2021","journal-title":"Br J Cardiol"},{"issue":"1134","key":"10.1016\/j.hrtlng.2024.04.001_bib0030","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/postgradmedj-2019-136867","article-title":"Audit of the prevalence and investigation of iron deficiency anaemia in patients with heart failure in hospital practice","volume":"96","author":"Simon","year":"2020","journal-title":"Postgrad Med J"},{"issue":"27","key":"10.1016\/j.hrtlng.2024.04.001_bib0031","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.hrtlng.2024.04.001_bib0032","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.hrtlng.2024.04.001_bib0033","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrtlng.2024.04.001_bib0034","unstructured":"World Health Organisation. Haemoglobin concentrations for the diagnosis of anaemia and assesment of severity. 2011. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/85839\/WHO_NMH_NHD_MNM_11.1_eng.pdf. Accessed April 27, 2023."}],"container-title":["Heart & Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956324000542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956324000542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T12:23:18Z","timestamp":1715430198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147956324000542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":34,"alternative-id":["S0147956324000542"],"URL":"https:\/\/doi.org\/10.1016\/j.hrtlng.2024.04.001","relation":{},"ISSN":["0147-9563"],"issn-type":[{"type":"print","value":"0147-9563"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The findings of a service evaluation on the practice of assessment and treatment of iron deficiency in people admitted to a UK hospital with decompensated Heart Failure","name":"articletitle","label":"Article Title"},{"value":"Heart & Lung","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrtlng.2024.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2024 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}